CLINICAL_TRIALS
trial_result
· 2024-03-12
Clinical Trial Update: Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating ibrutinib after intensive induction in previously untreated mantle cell lymphoma patients; status unavailable with results posted in 20…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma | Phase 2 | Status: UNKNOWN | Results posted: 2024-03-12